We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Werfen’s Aptiva Antiphospholipid Syndrome Immunoglobulin A (IgA) Reagent has received U.S. FDA 510(k) clearance and CE Mark under IVDR. More...
23 Sep 2026
Image Credit: Adobe Stock

New Donor Genetic Marker May Help Predict Stem Cell Transplant Success

New findings identify a donor genetic variant linked to improved survival and lower relapse, informing stem cell donor selection. More...
23 Sep 2026
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics and ReadyGo have initiated a collaboration to evaluate an integrated workflow for blood-based molecular testing at the point of need. More...
23 Sep 2026
Image: The findings reveal that individuals exposed to Borrelia burgdorferi, the bacterium that causes Lyme disease, are more than four times as likely to have antibodies against other tick-borne pathogens (Image Credit: Shutterstock)

Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens

New data show nearly one-third of Lyme-seropositive patients also have antibodies to other tick-borne pathogens. More...
23 Sep 2026
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

A new point-of-care blood test gains CE mark to detect stroke and flag large-vessel occlusion. More...
23 Sep 2026
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Werfen’s Aptiva Antiphospholipid Syndrome Immunoglobulin A (IgA) Reagent has received U.S. FDA 510(k) clearance and CE Mark under IVDR. More...
23 Sep 2026
Image: Graphical Abstract (Turner N, Keam S, Abdel-Wahab N, et al. B cell-guided inflammatory cascade perpetuates ICI-mediated colitis. Cell Reports (2026). doi:10.1016/j.celrep.2026.117969)

Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy

New findings show that blood-based B-cell activity helps predict immunotherapy-related colitis risk. More...
23 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
HPV Test
Allplex HPV28 Detection
Copyright © 2000-2026 Globetech Media. All rights reserved.